Atomic AI
Categories
AI Tool Description
Atomic AI
Atomic AI is an AI-driven platform that specializes in RNA drug discovery, utilizing machine learning and structural biology for precise molecular analysis. The company focuses on developing cutting-edge technologies to unlock the potential of RNA-based therapies.
Features and Capabilities
- AI-Driven RNA Drug Discovery: Atomic AI leverages advanced machine learning algorithms and deep learning foundation models to discover and design targeted small molecules, therapeutics, and tools that specifically interact with RNA molecules.
- Precise Molecular Analysis: The platform offers atomic precision in analyzing the structure and function of RNA molecules, enabling scientists and researchers to gain valuable insights into the intricate workings of RNA-based systems and potential drug targets.
- Proprietary Platform: Atomic AI provides a proprietary platform that integrates machine learning techniques with structural biology, allowing for the efficient identification, development, and optimization of RNA-targeted drugs and therapies.
- Collaborative Efforts: Atomic AI collaborates with leading experts in the field of RNA research, working together to advance the understanding and application of RNA-based medicines. Their research has been published in prestigious scientific journals such as Science.
- Investor Backing: Atomic AI has received support from prominent investors and venture capital firms, including Playground Global, 8VC, Greylock, Factory, AME Cloud Ventures, Not Boring, and AIX Ventures.
Contact Information
- General Inquiries: info@atomic.ai
- Business Development: bd@atomic.ai
Connect with Atomic AI
For more detailed information and to explore the innovative work of Atomic AI, please visit their official website: Atomic AI
Other related tools
Tempus is an AI-enabled precision medicine platform that leverages data and artificial intelligence to accelerate discovery, predict treatment effectiveness, identify clinical trials, and diagnose diseases earlier.
Owkin is an AI biotech company that integrates human and artificial intelligence to deliver better drugs and diagnostics at scale. They use AI to understand complex biology and accelerate medical research and development.
Exscientia AI is an AI-driven platform that revolutionizes drug discovery by combining AI algorithms with human expertise to rapidly and efficiently design and optimize drug molecules for clinical testing.